DR. JASON L GAGLIA, M.D.
Osteopathic Medicine at Joslin Pl, Boston, MA
License number
Massachusetts 212223
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
1 Joslin Pl ROOM 470, Boston, MA 02215
Phone
(617) 732-2675
(617) 732-2452 (Fax)
(617) 732-2452 (Fax)
Personal information
See more information about JASON L GAGLIA at radaris.comName
Address
Phone
16 Miner St UNIT 112, Boston, MA 02215
107 Avenue Louis Pasteur, Boston, MA 02115
211 Park St, Boston, MA 02215
211 Park Dr, Boston, MA 02215
931 Massachusetts Ave, Cambridge, MA 02139
Organization information
See more information about JASON L GAGLIA at bizstanding.comJoslin Diabetes Center - Richard Beaser MD
1 Joslin Pl #376, Boston, MA 02215
Doing business as:
Joslin Diabetes Center - Osama Hamdy MD<br>Joslin Diabetes Center - Lloyd Paul Aiello MD<br>Joslin Diabetes Center - John A D'Elia MD<br>Joslin Diabetes Center - Jason L Gaglia MD<br>Joslin Diabetes Center - Lyle D Mitzner MD<br>Joslin Diabetes Center - Martin J Abrahamson MD<br>Joslin Diabetes Center - George S Sharuk MD<br>Joslin Diabetes Center - Joan Elaine Larrabee MD<br>Joslin Diabetes Center - Melanie P Hoenig MD<br>Joslin Diabetes Center - Elizabeth S Halprin MD<br>Joslin Diabetes Center - Jennifer K Sun MD
Site:
Phone:
(617) 732-2400 (Phone)
Categories:
Physicians & Surgeons, Ophthalmology Physicians & Surgeons, Nephrology Physicians & Surgeons, ...
In business since:
1898
Products:
Clinics, Diabetes, Endocrinology, ...
Professional information
See more information about JASON L GAGLIA at trustoria.com
Jason L Gaglia, Boston MA
Jason L Gaglia, Boston MA
Specialties:
Endocrinologist
Address:
1 Joslin Pl, Boston, MA 02215
Education:
Harvard Medical School - Doctor of Medicine
Beth Israel Deaconess Medical Center - Fellowship - Endocrinology
Beth Israel Deaconess Medical Center - Residency - Internal Medicine
Beth Israel Deaconess Medical Center - Internship - Internal Medicine
Beth Israel Deaconess Medical Center - Fellowship - Endocrinology
Beth Israel Deaconess Medical Center - Residency - Internal Medicine
Beth Israel Deaconess Medical Center - Internship - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Dr. Jason L Gaglia, Boston MA - MD (Doctor of Medicine)
Dr. Jason L Gaglia, Boston MA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism
Address:
1 Joslin Pl, Boston 02215
(617) 732-2675 (Phone), (617) 732-2452 (Fax)
Harvard Vanguard Medical Associates - Kenmore
133 Brookline Ave, Boston 02215
(617) 421-1380 (Phone), (617) 421-2707 (Fax)
(617) 732-2675 (Phone), (617) 732-2452 (Fax)
Harvard Vanguard Medical Associates - Kenmore
133 Brookline Ave, Boston 02215
(617) 421-1380 (Phone), (617) 421-2707 (Fax)
Certifications:
Diabetes, Metabolism & Endocrinology, 2006, Internal Medicine, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1 Joslin Pl, Boston 02215
Harvard Vanguard Medical Associates - Kenmore
133 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Newton - Wellesley Hospital
2014 Washington St, Newton 02462
Harvard Vanguard Medical Associates - Kenmore
133 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Newton - Wellesley Hospital
2014 Washington St, Newton 02462
Education:
Medical School
Harvard Medical School
Beth Israel Deaconess Med Center
Harvard Medical School
Beth Israel Deaconess Med Center
Jason Louis Gaglia, Boston MA
Jason Louis Gaglia, Boston MA
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Endocrinology and Metabolism
Work:
Joslin Clin.
1 Joslin Pl, Boston, MA 02215
1 Joslin Pl, Boston, MA 02215
Education:
Harvard University(2001)
Compositions And Methods Related To Tim-3, A Th1-Specific Cell Surface Molecule
Compositions And Methods Related To Tim-3, A Th1-Specific Cell Surface Molecule
US Patent:
2004000, Jan 8, 2004
Filed:
Jan 30, 2003
Appl. No.:
10/354447
Inventors:
Vijay Kuchroo - Newton MA, US
Laurent Monney - Bulle, CH
Jason Gaglia - Boston MA, US
Edward Greenfield - Stoughton MA, US
Gordon Freeman - Brookline MA, US
Hanspeter Waldner - Cambridge MA, US
Laurent Monney - Bulle, CH
Jason Gaglia - Boston MA, US
Edward Greenfield - Stoughton MA, US
Gordon Freeman - Brookline MA, US
Hanspeter Waldner - Cambridge MA, US
International Classification:
A61K039/395
US Classification:
424/155100
Abstract:
The present invention provides compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is related to discovery of functional characteristics of TIM-3, a molecule that is preferentially expressed on the surface of Th1 cells. The methods are useful for treating disorders including cancer, infectious disease, allergy, asthma, and autoimmune disease.
Compositions And Methods Related To Tim-3, A Th1-Specific Cell Surface Molecule
Compositions And Methods Related To Tim-3, A Th1-Specific Cell Surface Molecule
US Patent:
8101176, Jan 24, 2012
Filed:
Nov 24, 2008
Appl. No.:
12/276977
Inventors:
Vijay K. Kuchroo - Newton Center MA, US
Laurent Monney - Cambridge MA, US
Jason L. Gaglia - Boston MA, US
Edward A. Greenfield - Stoughton MA, US
Gordon J. Freeman - Brookline MA, US
Hanspeter Waldner - Cambridge MA, US
Laurent Monney - Cambridge MA, US
Jason L. Gaglia - Boston MA, US
Edward A. Greenfield - Stoughton MA, US
Gordon J. Freeman - Brookline MA, US
Hanspeter Waldner - Cambridge MA, US
Assignee:
The Brigham and Women's Hospital, Inc. - Boston MA
Dana-Farber Cancer Institute, Inc. - Boston MA
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 39/395
US Classification:
4241301, 4241391, 4241371
Abstract:
The present invention provides compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is related to discovery of functional characteristics of TIM-3, a molecule that is preferentially expressed on the surface of Th1 cells. The methods are useful for treating disorders including cancer, infectious disease, allergy, asthma, and autoimmune disease.
Compositions And Methods Related To Tim 3, A Th1-Specific Cell Surface Molecule
Compositions And Methods Related To Tim 3, A Th1-Specific Cell Surface Molecule
US Patent:
2012031, Dec 13, 2012
Filed:
Dec 20, 2011
Appl. No.:
13/331387
Inventors:
Vijay K. Kuchroo - Newton Center MA, US
Laurent Monney - Bulle, CH
Jason L. Gaglia - Boston MA, US
Edward A. Greenfield - Stoughton MA, US
Gordon J. Freeman - Brookline MA, US
Hanspeter Waldner - Lemoyne PA, US
Laurent Monney - Bulle, CH
Jason L. Gaglia - Boston MA, US
Edward A. Greenfield - Stoughton MA, US
Gordon J. Freeman - Brookline MA, US
Hanspeter Waldner - Lemoyne PA, US
Assignee:
DANA-FARBER CANCER INSTITUTE, INC. - Boston MA
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
International Classification:
A61K 39/395, C12N 5/0783
US Classification:
4241721, 435375
Abstract:
The present invention provides compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is related to discovery of functional characteristics of TIM-3, a molecule that is preferentially expressed on the surface of Th1 cells. The methods are useful for treating disorders including cancer, infectious disease, allergy, asthma, and autoimmune disease.